At a glance
ClinicalIndex Comparison RecordN/ACompleted· 11 enrolled
Drug / intervention
ChapStick Lip Moisturizer Original +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the Sun Protection Factor (SPF) of Sunscreen Products According to the FDA Final Rule: Sunscreen Drug Products (2011)
In Brief
A clinical study evaluating ChapStick Lip Moisturizer Original, ChapStick Lip Moisturizer Mint, and 2 other interventions for Sunscreening Agents. Completed, enrolled 11 participants across 1 site.
Detailed Summary
The purpose of this study is to determine the static SPF of three sunscreen products (ChapStick Lip Moisturizer \[CLM\] Original, CLM Mint Flavour and CLM Black Cherry Flavour) using the methodology described in the Food and Drug Administration (FDA) Final Rule (2011).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSunscreening Agents
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartOct 2021
First PostedOct 2021
Primary CompletionNov 2021
TodayJul 2026
First PostedOct 20, 2021
Enrollment StartOct 19, 2021
Primary CompletionNov 4, 2021
TodayJul 2, 2026
Enrollment to primary: 15 daysPosted 4.7 years ago
Interventions
ChapStick Lip Moisturizer Originaldrug
Sunscreen lip balm.
ChapStick Lip Moisturizer Mintdrug
Sunscreen lip balm.
ChapStick Lip Moisturizer Black Cherrydrug
Sunscreen lip balm.
SPF Standard Sunscreendrug
SPF Standard (7 percent \[%\] Padimate-O and 3% Oxybenzone)